You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – GE, the Global Good Fund, and Access Bio today announced a licensing agreement to manufacture and distribute diagnostic technologies aimed at rapidly identifying asymptomatic malaria in low-resource nations.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.